U.S. Senator Richard Blumenthal is pushing to secure $791 million in federal funding for covid tests due to an increase in covid cases this summer. At a press conference at the Charter Oak Health Center in Hartford on Monday, Blumenthal described the increase in covid cases as “concerning" and said it was "not a reason for panic but for preparedness.”
The CDC reported 2,557 covid tests administered in Connecticut through the week of July 29, 2023, with 7.2% of tests indicating positive results. A total of 103 hospital admissions had positive covid test results.
Most covid tests are offered under Emergency Use Authorization (EUA) and have not undergone the rigorous testing required to obtain full authorization from the Federal Drug Administration (FDA). However, a handful of molecular SARS-CoV-2 diagnostic tests have been authorized through traditional premarket review pathways.
During the covid pandemic, the FDA issued EUAs for over 400 covid tests and collection kits, including: 278 molecular tests, 83 serology and other adaptive immune response tests, 63 antigen tests and 1 breathalyzer test.
The FDA has already revoked EUAs for over 50 covid tests.
The State of Connecticut distributed five different covid tests to residents for free at the beginning of 2022 from the following manufacturers: iHealthLabs, QuickVue, BinaxNOW, FlowFlex, and on/go.
All of the tests CT distributed were "antigen" tests capable of producing both false positive and false negative results. According to the FDA, as disease prevalence decreases, the percent of test results with antigen tests that are false positives increases, leading to false positive test results anywhere from 20% to 96% of the time.
Some of the tests that Connecticut distributed included potentially dangerous chemicals, such as sodium azide / 26628-22-8 (toxic to skin and if swallowed), Triton X-100/9002-93-1 (harmful if swallowed, serious eye damage), ProClin 300 (harmful if inhaled/ swallowed, severe skin burns and eye damage), and Pentahydrate/12179-04-3 (may damage fertility or the unborn child).
All of the tests provided by Connecticut experienced issues with cross-reactivity and could not rule out bacterial infection or co-infection with other viruses, such as SARS-CoV, MERS-CoV, mycoplasma pneumoniae, and human coronavirus HKU1.
The last thing the country needs is another covid "casedemic".